Shanghai Haohai Biological (06826.HK, 688366.SH) Publishes Next Day Disclosure Return Highlighting Recent Share Repurchases

Bulletin Express
Nov 04

Shanghai Haohai Biological Technology Co., Ltd. released a Next Day Disclosure Return dated 4 November 2025. The document confirms that the company’s H-share count remains at 38,529,240. A series of H-share repurchases have been recorded but not yet canceled, including 43,000 shares repurchased on 4 November 2025 at an average price of HKD 27.64.

For A shares, the total stands at 190,203,760 and 3,848,095 treasury shares, making for an overall total of 194,051,855. No additional A-share changes occurred on 4 November 2025. According to the disclosure, 330,200 H shares have been repurchased under a board-approved mandate dated 10 June 2025, which authorizes a maximum of 3,914,184 shares to be bought back. The mandate imposes a 30-day moratorium on certain new share issuances or related transfers following any repurchase, set to last until 4 December 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10